Germany: Fresenius taps bond markets for €750m over five years  

Fresenius Medical Care, a leading global provider of products and services for renal diseases, has placed €750m of five-year bonds. The bonds pay an annual coupon of 3.875% and were priced at 99.635% resulting in a yield of 3.957%, the equivalent of mid-swap plus 163bp. Bonds are rated Baa3/BBB/BBB- (Moody’s/S&P/Fitch). Joint leads and bookrunners are…

You must be a HMI Subscriber to view this content.

Subscribe Now »